🇺🇸 Influenza vaccine [inactivated] in United States
56 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 23 April 2025 – 23 April 2026
- Total reports: 56
Most-reported reactions
- Drug Interaction — 12 reports (21.43%)
- Pyrexia — 8 reports (14.29%)
- Headache — 7 reports (12.5%)
- Diarrhoea — 5 reports (8.93%)
- Contusion — 4 reports (7.14%)
- Cough — 4 reports (7.14%)
- Haemoptysis — 4 reports (7.14%)
- International Normalised Ratio Decreased — 4 reports (7.14%)
- Platelet Count Decreased — 4 reports (7.14%)
- Vomiting — 4 reports (7.14%)
Other Immunology / Infectious Disease approved in United States
Frequently asked questions
Is Influenza vaccine [inactivated] approved in United States?
Influenza vaccine [inactivated] does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Influenza vaccine [inactivated] in United States?
St. Petersburg Research Institute of Vaccines and Sera is the originator. The local marketing authorisation holder may differ — check the official source linked above.